TrialJournal of atherosclerosis and thrombosis2025

Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study.

Yusuke Kawachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.